Colorectal cancer is among the most common forms of cancer in Norway with over 4200 new cases annually. The center brings together experts in genetics, biology, bioinformatics, epidemiology, radiation therapy and surgery, aiming at improved and more tailored treatment for patients.
The KG Jebsen Centre for Colorectal Cancer Research is localised within Oslo University Hospital, and the members have complementary scientific background/fields of interest: genetics, biology, bioinformatics, epidemiology, oncology and surgery.
These skills, the use of cutting-edge technology and on-site know-how for clinical trials provide the means for rapid transfer of new research results into clinical practice in one of Europe’s largest cancer hospitals.
Prof. Ragnhild A. Lothe
Centre Leader, Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital (OUH) and Institute for Clinical Medicine, University of Oslo (UiO).
Prof. Guro E. Lind
Department of Molecular Oncology, Institute for Cancer Research, OUH, and Department of Biosciences, UiO.
Prof. Arild Nesbakken
Department of Gastrointestinal Surgery, OUH and Institute for Clinical Medicine, UiO.
Prof. Rolf I. Skotheim
Department of Molecular Oncology, Institute for Cancer Research, OUH, and Department of Informatics, UiO.
Dr. Marianne G. Guren,
Department of Oncology, OUH.
The center wishes to involve patients in the research and has therefore established a separate patient advicory board. The members of the Patient Council have all experience with bowel cancer either as patients or relatives. Group leaders and patient councils meet approx. once a month.
Members: Lars Reed, Torvald Stoltenberg, Jack Waitz og Marianne Guriby.